Volume 64, Pages S72-S77 (November 2003)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Erythropoietin should be part of congestive heart failure management
Iron status and iron supplementation in peritoneal dialysis patients
Anemia management in chronic kidney disease
Erythropoietin should be part of congestive heart failure management
Volume 64, Pages S72-S77 (November 2003)
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Volume 86, Issue 3, Pages (September 2014)
Reassessment of the care of the patient with chronic kidney disease
Volume 80, Issue 10, Pages (November 2011)
Volume 63, Issue 6, Pages (June 2003)
Volume 73, Issue 5, Pages (March 2008)
Volume 78, Pages S41-S45 (August 2010)
Kamyar Kalantar-Zadeh  Kidney International 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 74, Issue 12, Pages (December 2008)
Volume 70, Pages S21-S25 (December 2006)
Malnutrition and inflammation in peritoneal dialysis patients
George A. Kaysen, Burl R. Don
D. Batlle, P. Ramadugu, M.J. Soler  Kidney International 
A new era in phosphate binder therapy: What are the options?
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Joseph W. Eschbach, John W. Adamson  Kidney International 
Volume 78, Pages S33-S36 (August 2010)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
The epidemiology of chronic kidney disease
Volume 87, Issue 2, Pages (February 2015)
Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.
Edmund G. Lowrie  Kidney International 
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Elke Wühl, Otto Mehls, Franz Schaefer  Kidney International 
Volume 73, Issue 12, Pages (June 2008)
Recent experience with high-dose intravenous iron administration
New insights in uremic toxins
Günter Weiss, Florian Kronenberg  Kidney International 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
The value of ferric citrate, an iron-containing phosphate binder, might be different between Japan and the United States  Keitaro Yokoyama, Yukio Maruyama,
Microbiology and outcomes of peritonitis in North America
Nephrology in Latin America, with special emphasis on Brazil
Methods for guideline development
AGEs in foods: Do they play a role in uremia?
Counteracting progression of renal disease: A look into the future
The global challenge of chronic kidney disease
Homocysteine, renal function, and risk of cardiovascular disease
Volume 55, Issue 5, Pages (May 1999)
Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass 
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Phosphate binders on iron basis: A new perspective?
Organ transplantation goes to the movies
Volume 56, Pages S71-S74 (November 1999)
Volume 63, Issue 2, Pages (February 2003)
Volume 72, Issue 2, Pages (July 2007)
Volume 55, Pages S3-S16 (June 1999)
Volume 63, Issue 3, Pages (March 2003)
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
The hypothesis that abnormal BH4 metabolism impairs kidney function
Is complement a target for therapy in renal disease?
Volume 75, Issue 9, Pages (May 2009)
Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation  A.K. Singh, D.W. Coyne,
Strategies for iron supplementation: Oral versus intravenous
Volume 70, Issue 10, Pages (November 2006)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Volume 74, Issue 10, Pages (November 2008)
Volume 57, Pages S44-S48 (April 2000)
Presentation transcript:

Volume 64, Pages S72-S77 (November 2003) The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease  Daniel A. Blaustein, Michael H. Schwenk, Jyoti Chattopadhyay, Harinder Singh, Rachid Daoui, Radjeep Gadh, Morrell M. Avram  Kidney International  Volume 64, Pages S72-S77 (November 2003) DOI: 10.1046/j.1523-1755.64.s87.11.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 The mean serum ferritin concentrations in 55 patients at baseline, and at two and seven days' post 1000mg iron sucrose intravenously. All values were statistically significantly different from each other. Kidney International 2003 64, S72-S77DOI: (10.1046/j.1523-1755.64.s87.11.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 The mean transferrin saturations in 55 patients at baseline, and at two and seven days' post 1000mg iron sucrose intravenously. All values were statistically significantly different from each other. Kidney International 2003 64, S72-S77DOI: (10.1046/j.1523-1755.64.s87.11.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.